Hongliang Li Selected Research

gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)

4/2015	Corrigendum: Interferon regulatory factor 9 is critical for neointima formation following vascular injury.
1/2015	Interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury.
10/2014	Interferon regulatory factor 9 is critical for neointima formation following vascular injury.
9/2014	A critical role for interferon regulatory factor 9 in cerebral ischemic stroke.
1/2014	Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia/reperfusion injury.
1/2014	Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
8/2013	Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongliang Li Research Topics

Disease

51	Cardiomegaly (Heart Hypertrophy) 01/2022 - 03/2009
42	Inflammation (Inflammations) 02/2022 - 03/2009
34	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2016
30	Neoplasms (Cancer) 06/2022 - 08/2010
26	Fibrosis (Cirrhosis) 01/2021 - 03/2009
21	Insulin Resistance 01/2021 - 10/2011
17	Obesity 01/2022 - 01/2012
14	COVID-19 01/2022 - 01/2020
13	Atherosclerosis 01/2022 - 01/2012
13	Hypertrophy 01/2020 - 03/2009
12	Tachycardia (Tachyarrhythmias) 02/2022 - 01/2012
11	Heart Failure 12/2020 - 08/2010
11	Carcinogenesis 01/2020 - 03/2013
9	Fatty Liver 01/2022 - 02/2013
8	Ischemia 01/2022 - 09/2015
8	Reperfusion Injury 01/2022 - 01/2013
8	Stroke (Strokes) 01/2020 - 01/2013
7	Liver Diseases (Liver Disease) 01/2022 - 01/2018
7	Hypertension (High Blood Pressure) 01/2022 - 02/2009
6	Postural Orthostatic Tachycardia Syndrome 02/2022 - 07/2017
6	Cardiac Arrhythmias (Arrythmia) 08/2021 - 02/2010
6	Sinus Tachycardia 01/2021 - 03/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 02/2010
6	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 06/2013
6	Epilepsy (Aura) 06/2019 - 01/2015
6	Infarction (Infarctions) 12/2017 - 08/2013
6	Neointima 10/2017 - 02/2014
6	Body Weight (Weight, Body) 10/2016 - 05/2009
5	Brain Ischemia (Cerebral Ischemia) 01/2022 - 08/2013
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2014
5	Hyperglycemia 01/2021 - 02/2010
5	Hyperplasia 01/2021 - 06/2010
5	Necrosis 01/2021 - 01/2012
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 09/2015
5	Vascular System Injuries 10/2018 - 02/2014
5	Ischemic Stroke 12/2017 - 09/2014
5	Atherosclerotic Plaque (Atheroma) 01/2017 - 08/2013
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 03/2022 - 08/2020
4	Vascular Diseases (Vascular Disease) 01/2022 - 02/2014
4	Atrial Fibrillation 01/2021 - 08/2014
4	Metabolic Diseases (Metabolic Disease) 01/2021 - 09/2014
4	Graves Disease (Basedow Disease) 01/2021 - 08/2014
4	Myocardial Infarction 07/2015 - 01/2012
3	Disease Progression 01/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2010
24	AutoantibodiesIBA 03/2022 - 01/2012
24	LipidsIBA 01/2022 - 01/2012
18	Angiotensin IIIBA 01/2020 - 03/2009
14	Pharmaceutical PreparationsIBA 01/2022 - 09/2013
12	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2012
11	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2016 - 05/2009
10	Phosphotransferases (Kinase)IBA 01/2021 - 08/2010
8	CytokinesIBA 12/2022 - 01/2014
8	Biological ProductsIBA 10/2020 - 02/2013
8	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020 - 08/2013
8	Transcription Factors (Transcription Factor)IBA 01/2020 - 03/2013
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
7	Apolipoproteins E (ApoE)IBA 01/2022 - 08/2013
7	GTP-Binding Proteins (G-Protein)IBA 01/2021 - 08/2010
7	Adrenergic Agents (Adrenergic Drugs)IBA 12/2019 - 01/2012
7	mindinIBA 11/2017 - 10/2011
7	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 04/2015 - 08/2013
6	LigandsIBA 02/2022 - 10/2011
6	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2016
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 08/2013
6	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021 - 03/2013
6	Peptides (Polypeptides)IBA 01/2020 - 04/2015
6	Valproic Acid (Depakote)FDA LinkGeneric 06/2019 - 01/2015
6	CollagenIBA 01/2017 - 03/2009
5	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 03/2022 - 08/2020
5	MAP Kinase Kinase Kinase 5IBA 01/2022 - 05/2015
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2009
5	Interferon Regulatory FactorsIBA 01/2019 - 03/2013
5	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2017 - 03/2013
5	ApolipoproteinsIBA 01/2017 - 08/2013
5	NF-kappa B (NF-kB)IBA 12/2016 - 05/2009
5	Sirtuin 1IBA 01/2015 - 11/2012
4	Cholinergic Agents (Cholinergics)IBA 02/2022 - 01/2016
4	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2022 - 03/2013
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
4	CalciumIBA 01/2022 - 02/2010
4	Small Interfering RNA (siRNA)IBA 12/2021 - 01/2014
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2020 - 01/2020
4	Angiotensin Receptor AntagonistsIBA 11/2020 - 01/2020
4	Metformin (Glucophage)FDA LinkGeneric 10/2020 - 06/2011
4	MicroRNAs (MicroRNA)IBA 01/2020 - 03/2017
4	Mitogen-Activated Protein Kinase 3IBA 12/2016 - 05/2009
4	TNF Receptor-Associated Factor 3IBA 02/2016 - 08/2015
4	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2016 - 03/2009
4	Protein Kinases (Protein Kinase)IBA 01/2016 - 04/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022 - 06/2017
3	Hormones (Hormone)IBA 03/2022 - 10/2016
3	CholesterolIBA 01/2022 - 10/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 11/2012
3	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 02/2009
3	Muscarinic M2 ReceptorIBA 01/2021 - 06/2015

Therapy/Procedure

25	Therapeutics 01/2022 - 05/2009
5	Liver Transplantation 01/2022 - 02/2019
4	Radiotherapy 06/2022 - 12/2010
3	Operative Surgical Procedures 10/2021 - 01/2015